Nanofluidic devices have been investigated for over a decade as promising platforms for the controlled release of therapeutics.The nanochannel drug delivery system (nDS), a membrane fabricated with high precision silicon techniques, is capable of zero-order release of drugs by simply constraining molecular diffusion within nanochannels.